At a Glance
- Tasks: Lead DMPK strategy and ensure scientific excellence in drug development.
- Company: Recursion, a pioneering company in the pharmaceutical industry.
- Benefits: Competitive salary, bonuses, equity compensation, and hybrid work model.
- Other info: Join a dynamic team dedicated to innovative solutions in healthcare.
- Why this job: Shape the future of drug development with your expertise and vision.
- Qualifications: PhD in a related field and 15+ years of pharma experience.
The predicted salary is between 166500 - 208100 £ per year.
Recursion is seeking a visionary Head of DMPK in London responsible for leading DMPK strategy and ensuring high scientific rigor in drug development. The ideal candidate will have a PhD in a related field, 15+ years of experience in pharma, and a strong background in small molecule DMPK.
This hybrid role offers a competitive salary range from £166,500 to £208,100 plus bonuses and equity compensation.
Head of DMPK: Strategy Leader for Predictive ADME in London employer: Menlo Ventures
Recursion is an exceptional employer that fosters a culture of innovation and collaboration in the heart of London. With a commitment to employee growth, we offer competitive salaries, bonuses, and equity compensation, alongside opportunities for professional development in a dynamic and supportive environment. Join us to be part of a pioneering team dedicated to advancing drug development with scientific excellence.
